These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18958176)

  • 1. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
    Brudevold R; Hole T; Hammerstrøm J
    PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
    Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A; Hernández C; Simó R
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
    Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary hyperferritinemia syndrome and cataract].
    Feys J; Nodarian M; Aygalenq P; Cattan D; Bouccara AS; Beaumont C
    J Fr Ophtalmol; 2001 Oct; 24(8):847-50. PubMed ID: 11894536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating iron overload in patients with suspected liver disease and elevated serum ferritin.
    Cippà PE; Boucsein I; Adams H; Krayenbuehl PA
    Am J Med; 2014 Oct; 127(10):1011.e1-3. PubMed ID: 24662623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients.
    Hsiao TJ; Chen JC; Wang JD
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):167-72. PubMed ID: 14610526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of a hyperferritinemia].
    Sogni P; Buffet C
    Presse Med; 2013 Apr; 42(4 Pt 1):405-10. PubMed ID: 22795836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
    Brigant F; Hautefeuille V; Dadban A; Lok C; Nguyen-Khac E; Chaby G
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
    Turlin B; Mendler MH; Moirand R; Guyader D; Guillygomarc'h A; Deugnier Y
    Am J Clin Pathol; 2001 Aug; 116(2):263-70. PubMed ID: 11488074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of hyperferritinemia].
    Delwaide J; Giet D; Lamproye A; Belaïche J
    Rev Med Liege; 2006; 61(5-6):329-33. PubMed ID: 16910257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised serum ferritin concentration in hereditary hyperferritinemia cataract syndrome is not a marker for iron overload.
    Yin D; Kulhalli V; Walker AP
    Hepatology; 2014 Mar; 59(3):1204-6. PubMed ID: 24003015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
    Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
    Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.